Skip to main content
Independent and nonpartisan. SaveYourState is a civic information resource. It is not a government website and is not affiliated with any government agency, party, or campaign.

New York · 2025 Regular Session · Bill

A 10967: Enhances transparency in the prescription drug supply chain

In committee Official data

  1. Introduced
  2. In committee
  3. Passed one chamber
  4. Passed both chambers
  5. Enacted

Last official action: ·Record last updated:

Plain-language summary

A 10967 is a bill introduced in the New York House on April 14, 2026. According to its official title, it concerns: Enhances transparency in the prescription drug supply chain. Primary sponsor: Jake Blumencranz (Republican/Conservative). Most recent recorded action (April 14, 2026): REFERRED TO HEALTH.

Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written

Official summary

Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.

Enacts the "foreign drug transparency act" to provide information on the origin, manufacture and distribution of prescription drugs; requires a pharmacy benefit manager to maintain, and make available to pharmacies, health plans, and patients upon request, supply chain information for prescription drugs covered under its network.

Sponsors

Sponsors by party (alphabetical): Republican/Conservative 1

NameRolePartyChamberDistrict
Jake BlumencranzPrimary sponsorRepublican/ConservativeHouse15

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

  1. REFERRED TO HEALTH

Sources

  1. Open States / Plural (data from the official legislature website)
  2. Official legislature source